↓ Skip to main content

Dove Medical Press

Article Metrics

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
76 Mendeley
citeulike
1 CiteULike
Title
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting
Published in
Neuropsychiatric Disease and Treatment, September 2011
DOI 10.2147/ndt.s24196
Pubmed ID
Authors

Åsa Wallin, Minthon, Carina Wattmo

Abstract

In the absence of long-term, placebo-controlled studies of cholinesterase inhibitors in Alzheimer's disease (AD), analysis of the results of open-label trials becomes crucial. This study aimed to explore the three-year effects of galantamine treatment, as well as subgroups of response and adherence to treatment.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Netherlands 1 1%
Unknown 73 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 18%
Researcher 11 14%
Student > Master 9 12%
Student > Bachelor 9 12%
Student > Doctoral Student 4 5%
Other 14 18%
Unknown 15 20%
Readers by discipline Count As %
Medicine and Dentistry 26 34%
Psychology 10 13%
Agricultural and Biological Sciences 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Nursing and Health Professions 3 4%
Other 11 14%
Unknown 17 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2011.
All research outputs
#2,502,531
of 4,703,883 outputs
Outputs from Neuropsychiatric Disease and Treatment
#656
of 961 outputs
Outputs of similar age
#36,061
of 76,040 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#16
of 31 outputs
Altmetric has tracked 4,703,883 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 961 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 76,040 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.